New employees

December 2017​

In August Adam Bielski joined the Fluisense team as production manager and with his long standing experience within production facilities, Adam is going to be responsible for setting up, validating and scaling production of Fluispotter.

In October Inger Kühne took on the responsibility as Regulatory Affairs Manager in charge of the regulatory strategy towards CE-registration of Fluispotter.

In October we also hired Nikolas Velschow-Haagensen as usability engineer, responsible for planning, executing and documenting usability tests of Fluispotter in a clinical setting.

We are happy to have you all on-board. 

June 14 2017

Fluisense has full focus on CE approval of Fluispotter and in order to reach the goal we are happy that it has been possible to further strengthen the team with four new employees:

Laila Mathiasen is our new Operator working with clean room production. Niklas Blangsted is our new Brand Manager responsible for all customer directed documentation. Inger Kühne is our new Clinical Manager responsible for planning and monitoring of usability studies and clinical trials. Rasmus Mortensen is our new Engineer in the development team working on design verification.

Organisation changes in senior management

February 23 2017

Fluisense has terminated the coorporation with CEO Ulf S. Skimmeland on February 23, 2017. 

​Malene Schrøder takes over the position as CEO and Sten Velschow continues in his position as CTO. 

You are very welcome to contact Malene or Sten if you have questions or need further elaboration.

At the same time Sanne Larsen is appointed Senior Project Manager, responsible for Design Development.

​Fluisense Hires production supervisor Anita Gundorph, Senior verification engineer Sanne larsen and operator Helle key jensen

February 1 2017

We are ​happy to announce that we have expanded our team in Allerød with three strong ressources. 

Anita Gundorph is working as production supervisor and operator and Helle Key Jensen has just joined the production team as operator both in the clean room and in ESD-protected production. 

Sanne Larsen is responsible for planning and performing verification activities together with the engineering team leading towards CE approval of Fluispotter later this year. 

About us...


December 21 2016

Fluisense ApS has been granted European patent on our Multilumen Catheter. Patent no. EP 2884895. Priority claimed in April 2013.


May 25 2016

Fluisense ApS has been granted European patent on Fluispotter System. Patent no. EP 2884896. Priority claimed in April 2013.

​innovation fund denmark is investing in the clinical validation of Fluispotter

February 18 2016

​Innovation Fund Denmark has granted Fluisense 5.8 mio DKK to test the clinical value of Fluispotter as a diagnostic tool in patients. The project is a three year collaboration between Fluisense, Dept. of Clinical Biochemistry and Dept. of Endocrinology at Rigshospitalet and Dept. of Paediatrics at Herlev Hospital. The device will be used to measure stress hormones in adult and adolescent patients suffering from hormonal disorders that are very challenging and time consuming to diagnose with available procedures. For more information about the project please contact Project Manager Malene Schrøder, COO.

For a Danish project description, please refer to the website of Innovation Fund Denmark:

Fluisense hires Ditte maymann as executive management assistant

October 1 2015

​After working with Ditte as a consultant for over two years it is a pleasure to welcome her on-board . Ditte will be responsible for logistics and recruitment. She will be doing practical work in on-going and new development projects as well as in production.​ 

Patent granted in japan

July 31 2015

​Fluisense ApS has got granted and validated patent in Japan. The patent was published in Patent Gazette on July 8th 2015. Patent no. JP 5746973. Priority claimed in December 2008.

fluisense presents feasibility study at "Minipig research forum" in rome

May 27 2015

As invited speaker at the Minipig Research Forum (May 21-22, 2015) Sten Velschow presented the outcome of a collaboration between Ellegaard Göttingen Minipigs A/S, CiToxLAB Scantox A/S and Fluisense ApS. 

Fluispotter was tested on Minipigs in a small-scale 24 hour PK-feasibility study, where the pigs were dosed with a test substance and 20 blood samples collected, while the pigs were in their pens. If you want to learn more about the study please contact Fluisense here.

fluisense in medwatch

May ​13 2015

As a consequence of a succesfull dialogue with the new initiative "One Entry" ("Én Indgang") to Capital Region Denmark, Sten Velschow was interviewed for MedWatch. You can read the full article in MedWatch here.

fluisense hires electronics & software engineer Jesper Jakobsen

January 5 2015

We are happy to announce that we have hired Jesper Jakobsen to work for us as electronics and software engineer. Jesper holds a Bachelor's degree in electrical engineering​ and will be responsible for the future development and maintenance of embedded software and user interface for the Fluispotter.

We are happy to welcome Jesper to the Fluisense team !

Fluisense hires mechanical engineer Fanny Hauterat​

November 21 2014

​We are happy to announce that Fanny Hauterat has been hired to work for us as a mechanical design engineer. Fanny holds a Master's degree in mechanical engineering and industrial design, preceded by a bachelor in mechanical engineering and production. All skills relevant for Fluisense in the future development, refinement and production of the Fluispotter system.

Working as a junior mechanical engineer at Attention Design during her studies, Fanny already has a great insight into the mechanical construction and the assembly process of the Fluispotter. Attention Group have been our closest partner in the design, engineering and production of main parts for the Fluispotter over the last three years and this makes it obvious why we are very happy to welcome Fanny on-board.

Two International patent applications published

​October 24 2014

Two international patent applications have been published under PCT as 'WO 2014-169923 Multi Lumen Catheter' and 'WO 2014-169924 Improved Fluid Sampling System'.

First successful 24-hour study with Fluispotter​

July 4 2014​

​The small wearable Fluispotter has just finished taking a full 24-hour blood profile from a freely moving pig housed in its pen. The 70 gram device was mounted on the pig under full anaesthesia and placed securely in the pocket of a jacket. After the surgery the pig was replaced to its pen to wake up.

Fluispotter performed as planned for the duration of the study; hence it maintained patency of the catheter and extracted blood samples at the predetermined time points. The sampling was fully automatic and unsupervised.

The pig was dosed with Acetaminophen and the resulting Dried Blood Spot samples will be analyzed at the University of Copenhagen and will generate a PK-curve.​


April 16 2014

​Fluisense will be present and exhibiting Fluispotter at the 44th Annual ScandLAS Symposium in Stockholm at the Waterfront Congress Center, from the 24th to 26th of April 2014. 

Come and meet Sten Velschow and Malene Schrøder at the Fluisense booth and get an introduction to the Fluispotter. We will be showing an eye-catching 3D-video presentation of the device.​

​Patent granted in selected european countries

Jan 6 2014

​Fluisense ApS has now got granted and validated patent in Belgium, Denmark, Germany, France, Ireland, Netherlands, Sweden, Switzerland and United Kingdom.

First exhibition at ScandLas 2013 in Tallinn April 16th to 19th

Apr 18 2013

From April 16th to 19th Fluisense attended the 43rd Annual ScandLAS Symposium in Tallinn as exhibitors. Malene Schrøder was there for the first public showing of our portable automated blood sampling system for laboratory animals, the Fluispotter!


NEW Employees

Fluisense has full focus on CE approval of Fluispotter and in order to reach the goal we are happy that is has been possible to strengthen the team with four new employees.


Organisation changes

Malene Schrøder takes over the position as CEO. Sten Velschow continues as CTO.


Fluisense hires

Fluisense has added three strong resources to the team; we are happy to welcome Anita Gundorph, Sanne Larsen and Helle Key Jensen.



Fluisense has been granted patent in Europe. EP 2884895.


Patent granted in Europe

Fluisense has been granted patent in Europe. EP 2884896.


Innovation Fund Denmark is investing in the clinical validation of Fluispotter

Fluisense has been granted 5.8 mio DKK to test Fluispotter in a 3 year project with Rigshospitalet and Herlev Hospital.


COmpany info

Fluisense ApS

CVR/VAT: 32780571


Gydevang 20A

DK-3450 Allerød



Phone: +45 25 94 05 95